{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:28:44Z","timestamp":1648794524112},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ralph H. Johnson VAMC"},{"name":"VA BLR&D Merit Award","award":["(2 I01 BX000904-04)"],"award-info":[{"award-number":["(2 I01 BX000904-04)"]}]}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tcm.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T21:49:38Z","timestamp":1456350578000},"page":"429-432","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial Commentary: Understanding Marfan syndrome, or \u201chow not to invent the light bulb\u201d"],"prefix":"10.1016","volume":"26","author":[{"given":"Jeffrey A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2016.02.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2015.12.003","article-title":"Recent Progress in Understanding the Natural and Clinical Histories of the Marfan Syndrome","author":"Pyeritz","year":"2016","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.tcm.2016.02.005_bib2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/hmg\/4.suppl_1.1799","article-title":"Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders","volume":"4","author":"Dietz","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.tcm.2016.02.005_bib3","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1093\/emboj\/16.22.6659","article-title":"Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils","volume":"16","author":"Yuan","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.tcm.2016.02.005_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1357-2725(98)00109-5","article-title":"The fibrillins","volume":"31","author":"Ramirez","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.tcm.2016.02.005_bib5","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","volume":"96","author":"Pereira","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2016.02.005_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcm.2016.02.005_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2016.02.005_bib8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tcm.2016.02.005_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Cassis LA Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tcm.2016.02.005_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.23.5.587","article-title":"Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression","volume":"23","author":"Everett","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.02.005_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0895-7061(99)00152-1","article-title":"Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells","volume":"13","author":"Fukuda","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.tcm.2016.02.005_bib12","doi-asserted-by":"crossref","first-page":"F278","DOI":"10.1152\/ajprenal.00139.2003","article-title":"Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1","volume":"286","author":"Naito","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.tcm.2016.02.005_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s001099900028","article-title":"Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells","volume":"77","author":"Wolf","year":"1999","journal-title":"J Mol Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000103205","article-title":"Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease)","volume":"74","author":"Cottin","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.tcm.2016.02.005_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-006-0078-1","article-title":"Recent progress in genetics of Marfan syndrome and Marfan-associated disorders","volume":"52","author":"Mizuguchi","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.tcm.2016.02.005_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.105.537340","article-title":"Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections","volume":"112","author":"Pannu","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.005_bib18","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1074\/jbc.M806962200","article-title":"p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice","volume":"284","author":"Carta","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2016.02.005_bib19","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","article-title":"Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism","volume":"111","author":"Rodriguez-Vita","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.02.005_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tcm.2016.02.005_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tcm.2016.02.005_bib22","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan\u05f3s syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan\u05f3s syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.tcm.2016.02.005_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.tcm.2016.02.005_bib26","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.02.005_bib27","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","article-title":"MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome","volume":"110","author":"Xiong","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.02.005_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coph.2010.11.003","article-title":"AT1 receptors as mechanosensors","volume":"11","author":"Mederos","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.tcm.2016.02.005_bib29","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1096\/fj.12-222299","article-title":"Shear stress activates extracellular signal-regulated kinase 1\/2 via the angiotensin II type 1 receptor","volume":"27","author":"Ramkhelawon","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.tcm.2016.02.005_bib30","doi-asserted-by":"crossref","first-page":"28271","DOI":"10.1074\/jbc.M114.585067","article-title":"Allosteric modulation of beta-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch","volume":"289","author":"Tang","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2016.02.005_bib31","first-page":"288fs221","volume":"7","author":"Dietz","year":"2015","journal-title":"One integrin to rule them all? Sci Transl Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib32","doi-asserted-by":"crossref","first-page":"288ra279","DOI":"10.1126\/scitranslmed.aaa5094","article-title":"The alphavbeta1 integrin plays a critical in vivo role in tissue fibrosis","volume":"7","author":"Reed","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tcm.2016.02.005_bib33","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1097\/MIB.0b013e3182a8452e","article-title":"Increased activation of latent TGF-beta1 by alphaVbeta3 in human Crohn\u05f3s disease and fibrosis in TNBS colitis can be prevented by cilengitide","volume":"19","author":"Li","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tcm.2016.02.005_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/hep.23144","article-title":"Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis","volume":"50","author":"Patsenker","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tcm.2016.02.005_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/brain\/aws351","article-title":"Integrin control of the transforming growth factor-beta pathway in glioblastoma","volume":"136","author":"Roth","year":"2013","journal-title":"Brain"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T22:52:00Z","timestamp":1536965520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1050173816000499"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2016.02.005","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial Commentary: Understanding Marfan syndrome, or \u201chow not to invent the light bulb\u201d","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}